PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $502,000 | -28.6% | 500 | -99.4% | 0.00% | -62.5% |
| Q1 2020 | $703,000 | -2.2% | 82,200 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $719,000 | -70.1% | 82,200 | -63.2% | 0.01% | -75.0% |
| Q3 2019 | $2,403,000 | -14.9% | 223,200 | 0.0% | 0.03% | -8.6% |
| Q2 2019 | $2,824,000 | +398.1% | 223,200 | +1427.3% | 0.04% | +400.0% |
| Q1 2019 | $567,000 | -91.9% | 14,614 | -95.8% | 0.01% | -93.5% |
| Q4 2018 | $7,035,000 | -51.5% | 345,737 | +9.3% | 0.11% | -44.0% |
| Q3 2018 | $14,498,000 | +133.4% | 316,200 | +201.1% | 0.19% | +96.9% |
| Q2 2018 | $6,211,000 | +34.2% | 105,000 | +54.4% | 0.10% | +24.1% |
| Q1 2018 | $4,628,000 | +14.2% | 68,000 | +65.9% | 0.08% | +12.9% |
| Q4 2017 | $4,053,000 | -41.1% | 41,000 | -28.7% | 0.07% | -41.7% |
| Q3 2017 | $6,886,000 | +60.8% | 57,500 | +17.3% | 0.12% | +50.0% |
| Q2 2017 | $4,283,000 | -25.5% | 49,000 | -68.3% | 0.08% | -27.9% |
| Q1 2017 | $5,748,000 | +71.0% | 154,500 | +41.1% | 0.11% | +44.2% |
| Q4 2016 | $3,361,000 | -26.3% | 109,500 | +61.0% | 0.08% | -30.0% |
| Q3 2016 | $4,559,000 | +66.3% | 68,000 | -26.1% | 0.11% | +54.9% |
| Q2 2016 | $2,741,000 | -13.9% | 92,000 | -15.6% | 0.07% | -11.2% |
| Q1 2016 | $3,184,000 | -51.8% | 109,000 | +29.3% | 0.08% | -54.8% |
| Q4 2015 | $6,609,000 | +45.4% | 84,300 | +39.8% | 0.18% | +58.0% |
| Q3 2015 | $4,544,000 | +34.2% | 60,300 | +107.9% | 0.11% | +60.0% |
| Q2 2015 | $3,386,000 | -15.7% | 29,000 | +70.6% | 0.07% | -13.6% |
| Q1 2015 | $4,015,000 | +51.5% | 17,000 | +21.4% | 0.08% | +47.3% |
| Q4 2014 | $2,650,000 | – | 14,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |